1. British Pharmacopoeia (2018) British Pharmacopoeia Commission. The Stationary Office, London, London
2. Davis KL, Nappi JM (2003) The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonist. Clin Ther 25(11):2647–2668. https://doi.org/10.1016/s0149-2918(03)80326-0
3. Shailaja B et al (2015) A rapid assay method development and validation for the estimation of Eplerenone in tablets by UV spectrophotometry. Int J Pharm Pharm Sci 7:327–330
4. Ganure A et al (2011) Spectrophotometric determination of eplerenone in pharmaceutical bulk and tablet dosage. Der Pharma Chemica 3:566–571
5. Naina K, Brajesh M, Shashank S (2010) Development and validation of UV-spectrophotometric determination of Eplerenone in bulk and tablets. Int J Pharm Life Sci 1:231–233